Obesity rates and the incidence of malignant thyroid nodules have been increasing among younger patients in the US; there may be an association.
A single preoperative dose of dexamethasone reduces rates of postoperative hypocalcemia and voice dysfunction in patients undergoing thyroidectomy.
While calcitonin is considered standard of care for the diagnosis and follow-up of medullary thyroid cancer, researchers may have found a potentially more reliable marker.
Investigators assessed the relationship between intraoperative measurements obtained via laser speckle contrast imaging and outcomes following total thyroidectomy.
The sNDA is supported by data from the phase 3 COSMIC-311 study.
In a phase 2 trial, lenvatinib produced an objective response rate of about 3%.
Researchers defined the clinical features of pediatric patients with thyroid nodules in order to assess the risk of malignancy.
The American Heart Association released a statement regarding cardiac toxicities and their management in patients with arrhythmic complications while undergoing treatment for cancer.
Researchers from the University of North Carolina at Chapel Hill analyzed mortality data to determine whether causes of death related to obesity and cancer were associated with trends over time.
Cabozantinib significantly improved progression-free survival, and there was a trend toward improved overall survival.
Researchers evaluated the utility of ultrasound characteristics for refining malignancy risk to inform the management of cytologically indeterminate pediatric thyroid nodules.